Topics

Darzalex, Ibrance among latest SMC decisions

07:40 EDT 9 Jul 2019 | PharmaTimes

The Scottish Medicines Consortium (SMC) has announced its latest round of decisions for NHS Scotland, publishing advice accepting three new medicines.

Original Article: Darzalex, Ibrance among latest SMC decisions

NEXT ARTICLE

More From BioPortfolio on "Darzalex, Ibrance among latest SMC decisions"

Quick Search